1.Retention Esophagitis as a Significant Clinical Predictor of Progression to Esophageal Cancer in Achalasia.
Haewon KIM ; Hyojin PARK ; HeeSeung CHOI ; Yooju SHIN ; Hyunsung PARK ; Young Hoon YOUN ; Jie Hyun KIM
Clinical Endoscopy 2018;51(2):161-166
BACKGROUND/AIMS: Chronic liquid and/or food stasis caused by retention esophagitis (RE) in achalasia is a notable endoscopic finding because of the presence of a thickened or whitish esophageal mucosa and histologically altered squamous hyperplasia. We aimed to identify the clinical features of RE associated with achalasia and to clarify the clinical definition of RE in achalasia as a precancerous lesion identified by analyzing biomarker expressions. METHODS: From 2006 to 2015, we retrospectively reviewed 37 patients with achalasia without previous treatment. Among them, 21 patients had diagnostic findings of RE (RE+) and 16 patients had no diagnostic findings of RE (RE−). Immunohistochemical staining of p53, p16, and Ki-67 was performed on the endoscopic biopsy tissues from the patients with achalasia and 10 control patients with non-obstructive dysphagia. RESULTS: The symptom duration and transit delay were significantly longer in the RE+ group than in the RE− group. We found particularly high p53 positivity rates in the RE+ group (p<0.001). The rate of p16 expression was also significantly higher in the RE+ group than in the other two groups (p=0.003). CONCLUSIONS: A high p53 expression rate was more frequently found in the RE+ group than in the other two groups. RE could be a meaningful clinical feature of achalasia for predicting esophageal carcinogenesis.
Biopsy
;
Carcinogenesis
;
Deglutition Disorders
;
Esophageal Achalasia*
;
Esophageal Neoplasms*
;
Esophagitis*
;
Humans
;
Hyperplasia
;
Mucous Membrane
;
Retrospective Studies
;
Tumor Suppressor Protein p53
2.Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
June Key CHUNG ; Hyun Woo KIM ; Haewon YOUN ; Gi Jeong CHEON
Nuclear Medicine and Molecular Imaging 2018;52(5):325-326
Although radioiodine has been applied in thyroid diseases including carcinoma for over 70 years, it was only in 1996 that the basic molecular mechanism of iodine uptake was identified. Iodide is actively transported into the thyroid via a membrane glycoprotein known as sodium iodide symporter (NIS). NIS mediates radioiodine uptake into thyroid normal and cancer cells. The knowledge on NIS expression has provided scientific background to the empirical management of thyroid carcinoma. Based on recent studies of the NIS gene, this paper provides current clinical applications and future studies.
Genetic Therapy
;
Humans
;
Iodine
;
Ion Transport
;
Membrane Glycoproteins
;
Sodium Iodide
;
Sodium
;
Theranostic Nanomedicine
;
Thyroid Diseases
;
Thyroid Gland
;
Thyroid Neoplasms
3.Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
June Key CHUNG ; Hyun Woo KIM ; Haewon YOUN ; Gi Jeong CHEON
Nuclear Medicine and Molecular Imaging 2018;52(5):325-326
Although radioiodine has been applied in thyroid diseases including carcinoma for over 70 years, it was only in 1996 that the basic molecular mechanism of iodine uptake was identified. Iodide is actively transported into the thyroid via a membrane glycoprotein known as sodium iodide symporter (NIS). NIS mediates radioiodine uptake into thyroid normal and cancer cells. The knowledge on NIS expression has provided scientific background to the empirical management of thyroid carcinoma. Based on recent studies of the NIS gene, this paper provides current clinical applications and future studies.
4.Inorganic Phosphorus and Potassium Are Putative Indicators of Delayed Separation of Whole Blood
Jae-Eun LEE ; Maria HONG ; Seul-Ki PARK ; Ji-In YU ; Jin-Sook WANG ; Haewon SHIN ; Jong-Wan KIM ; Bok-Ghee HAN ; So-Youn SHIN
Osong Public Health and Research Perspectives 2016;7(2):90-95
Objectives:
The delayed separation of whole blood can influence the concentrations of circulating blood components, including metabolites and cytokines. The aim of this study was to determine whether clinical-biochemistry analytes can be used to assess the delayed separation of whole blood.
Methods:
We investigated the plasma and serum concentrations of five clinical-biochemistry analytes and free hemoglobin when the centrifugation of whole blood stored at 4°C or room temperature was delayed for 4 hours, 6 hours, 24 hours, or 48 hours, and compared the values with those of matched samples that had been centrifuged within 2 hours after whole-blood collection.
Results:
The inorganic phosphorus (IP) levels in the plasma and serum samples were elevated ≥ 1.5-fold when whole-blood centrifugation was delayed at room temperature for 48 hours. Furthermore, the IP levels in the plasma samples showed excellent assessment accuracy [area under the receiver-operating-characteristic curve (AUC) > 0.9] after a 48-hour delay in whole-blood separation, and high sensitivity (100%) and specificity (95%) at an optimal cutoff point. The IP levels in the serum samples also exhibited good assessment accuracy (AUC > 0.8), and high sensitivity (81%) and specificity (100%). The potassium (K+) levels were elevated 1.4-fold in the serum samples following a 48-hour delay in whole-blood separation. The K+ levels showed excellent assessment accuracy (AUC > 0.9) following a 48-hour delay in whole-blood separation, and high sensitivity (95%) and specificity (91%) at an optimal cutoff point.
Conclusion
Our study showed that the IP and K+ levels in the plasma or serum samples could be considered as putative indicators to determine whether whole-blood separation had been delayed for extended periods.

Result Analysis
Print
Save
E-mail